Omega Diagnostics Group PLC Grant of Share Options (2383V)

TIDMODX

RNS Number : 2383V

Omega Diagnostics Group PLC

02 December 2019

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Grant of Share Options and Notification of Director / PDMR Dealings

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that the Group's Remuneration Committee and the Board have approved the grant of 500,000 options ("New Options") over ordinary shares of 4 pence each ("Ordinary Shares") to Jeremy Millard, Non-Executive Director, pursuant to the Group's existing share option schemes.

All New Options were granted with an exercise price of 10 pence each, being the closing middle market price on 29 November 2019. The New Options will vest over three years, one third vesting on each anniversary of the grant date.

The grant of 500,000 New Options equates to 0.33 per cent. of the Group's current issued share capital. In total, 9,420,406 options are now under grant but not exercised, which equates to 6.3 per cent. of the Group's current issued share capital.

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts:

 
 Omega Diagnostics Group PLC                                  Tel: [phone] 
 Bill Rhodes, Interim Non-Executive                     www.omegadiagnostics.com 
  Chairman 
  Colin King, Chief Executive 
 Kieron Harbinson, Group Finance 
  Director 
                                                               Mob: [phone] 
 
 finnCap Ltd                                                  Tel: [phone] 
 Geoff Nash/Hannah Boros (Corporate 
  Finance) 
 Camille Gochez (Corporate Broking) 
 
 Walbrook PR Limited                  Tel: [phone] or [e-mail] 
 Paul McManus                                                 Mob: [phone] 
 Lianne Cawthorne                                             Mob: [phone] 
 
 
      Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name:                                      Jeremy Millard 
     -----------------------------------------  ----------------------------------------------------------------- 
      Reason for the notification 
     ------------------------------------------------------------------------------------------------------------ 
 a)   Position/status:                           Non-Executive Director 
     -----------------------------------------  ----------------------------------------------------------------- 
 b)   Initial notification/Amendment:            Initial Notification 
     -----------------------------------------  ----------------------------------------------------------------- 
      Details of the issuer, emission allowance market participant, auction 
       platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------------------------------------------ 
 a)   Name:                                      Omega Diagnostics Group Plc 
     -----------------------------------------  ----------------------------------------------------------------- 
 b)   LEI:                                       2138007U9P4BTZTYIR92 
     -----------------------------------------  ----------------------------------------------------------------- 
      Details of the transaction(s): section to be repeated for (i) each 
       type of instrument; (ii) each type of transaction; (iii) each date; 
       and (iv) each place where transactions have been conducted 
     ------------------------------------------------------------------------------------------------------------ 
 a)   Description of the financial instrument,   Ordinary Shares of 0.5 pence each 
       type of instrument:                        GB00B1VCP282 
       Identification code: 
     -----------------------------------------  ----------------------------------------------------------------- 
 b)   Nature of the transaction:                 Grant of options over Ordinary Shares 
     -----------------------------------------  ----------------------------------------------------------------- 
 c)   Price(s) and volume(s):                     Price(s)    Volume(s) 
                                                   n/a         500,000 
                                                              ---------- 
     -----------------------------------------  ----------------------------------------------------------------- 
 d)   Aggregated information:                    Single transaction as in 4 c) above Price(s)   Volume(s)   Total 
        *    Aggregated volume:                    n/a        500,000     n/a 
                                                             ----------  ------ 
 
        *    Price: 
     -----------------------------------------  ----------------------------------------------------------------- 
 e)   Date of the transaction:                   2 December 2019 
     -----------------------------------------  ----------------------------------------------------------------- 
 f)   Place of the transaction:                  n/a 
     -----------------------------------------  ----------------------------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

MSCFSSFAFFUSELE

(END) Dow Jones Newswires

December 02, 2019 04:00 ET (09:00 GMT)